Detailed information for compound 992760

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 301.41 | Formula: C15H19N5S
  • H donors: 1 H acceptors: 2 LogP: 2.53 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: CN1CCN(CC1)c1nc(N)nc(c1)Sc1ccccc1
  • InChi: 1S/C15H19N5S/c1-19-7-9-20(10-8-19)13-11-14(18-15(16)17-13)21-12-5-3-2-4-6-12/h2-6,11H,7-10H2,1H3,(H2,16,17,18)
  • InChiKey: YVNKBLKIGVQRLB-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus Histamine H4 receptor Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Onchocerca volvulus Histamine H4 receptor   391 aa 406 aa 22.9 %
Onchocerca volvulus Histamine H4 receptor   391 aa 362 aa 25.4 %
Schistosoma japonicum ko:K04136 adrenergic receptor, alpha 1b, putative Histamine H4 receptor   391 aa 401 aa 26.2 %
Onchocerca volvulus Mitochondrial inner membrane protein homolog Histamine H4 receptor   391 aa 363 aa 27.3 %
Loa Loa (eye worm) hypothetical protein Histamine H4 receptor   391 aa 376 aa 24.5 %
Schistosoma mansoni biogenic amine (5HT) receptor Histamine H4 receptor   391 aa 396 aa 25.8 %
Echinococcus granulosus g protein coupled receptor Histamine H4 receptor   391 aa 327 aa 24.2 %
Echinococcus multilocularis serotonin receptor Histamine H4 receptor   391 aa 406 aa 24.4 %
Schistosoma mansoni amine GPCR Histamine H4 receptor   391 aa 426 aa 23.9 %
Schistosoma japonicum ko:K04153 5-hydroxytryptamine (serotonin) receptor 1A, putative Histamine H4 receptor   391 aa 342 aa 24.9 %
Onchocerca volvulus Histamine H4 receptor   391 aa 401 aa 22.7 %
Echinococcus granulosus thyrotropin releasing hormone receptor Histamine H4 receptor   391 aa 355 aa 21.7 %
Echinococcus multilocularis neuropeptides capa receptor Histamine H4 receptor   391 aa 417 aa 21.8 %
Schistosoma japonicum ko:K04135 adrenergic receptor, alpha 1a, putative Histamine H4 receptor   391 aa 390 aa 24.4 %
Onchocerca volvulus 26S proteasome non-ATPase regulatory subunit 1 homolog Histamine H4 receptor   391 aa 331 aa 24.5 %
Brugia malayi sulfakinin receptor protein Histamine H4 receptor   391 aa 344 aa 19.5 %
Echinococcus granulosus biogenic amine 5HT receptor Histamine H4 receptor   391 aa 405 aa 24.2 %
Echinococcus multilocularis thyrotropin releasing hormone receptor Histamine H4 receptor   391 aa 355 aa 21.7 %
Schistosoma japonicum ko:K04209 neuropeptide Y receptor, invertebrate, putative Histamine H4 receptor   391 aa 385 aa 20.5 %
Brugia malayi Serotonin/octopamine receptor family protein 7 Histamine H4 receptor   391 aa 374 aa 25.9 %
Schistosoma japonicum ko:K04255 opsin 4 (melanopsin), putative Histamine H4 receptor   391 aa 396 aa 19.7 %
Loa Loa (eye worm) hypothetical protein Histamine H4 receptor   391 aa 377 aa 22.8 %
Schistosoma japonicum ko:K04134 cholinergic receptor, invertebrate, putative Histamine H4 receptor   391 aa 374 aa 26.5 %
Schistosoma japonicum ko:K04145 dopamine receptor D2, putative Histamine H4 receptor   391 aa 391 aa 25.1 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma cruzi inosine-5'-monophosphate dehydrogenase, putative 0.0205 1 0.5
Trypanosoma brucei GMP reductase 0.0205 1 0.5
Mycobacterium tuberculosis Probable inosine-5'-monophosphate dehydrogenase GuaB2 (imp dehydrogenase) (inosinic acid dehydrogenase) (inosinate dehydrogenase 0.0205 1 1
Loa Loa (eye worm) IMP dehydrogenase 1 0.0205 1 1
Mycobacterium leprae Probable inosine-5'-monophosphate dehydrogenase GuaB3 (IMP dehydrogenase 2) (inosinic acid dehydrogenase) (inosinate dehydrogena 0.0112 0.1995 0.1633
Trypanosoma brucei inosine-5'-monophosphate dehydrogenase 0.0205 1 0.5
Onchocerca volvulus Putative GMP reductase 0.0088 0 0.5
Wolbachia endosymbiont of Brugia malayi IMP dehydrogenase 0.0205 1 0.5
Trypanosoma cruzi inosine-5'-monophosphate dehydrogenase, putative 0.0205 1 0.5
Plasmodium falciparum inosine-5'-monophosphate dehydrogenase 0.02 0.9567 0.5
Mycobacterium ulcerans inosine 5-monophosphate dehydrogenase 0.02 0.9567 0.9548
Echinococcus multilocularis inosine 5' monophosphate dehydrogenase 2 0.0205 1 0.5
Echinococcus granulosus inosine 5' monophosphate dehydrogenase 2 0.0205 1 0.5
Mycobacterium ulcerans inosine 5'-monophosphate dehydrogenase 0.0205 1 1
Trypanosoma cruzi inosine-5'-monophosphate dehydrogenase, putative 0.0205 1 0.5
Leishmania major inosine-5-monophosphate dehydrogenase 0.0205 1 0.5
Schistosoma mansoni inosine-5-monophosphate dehydrogenase 0.0205 1 0.5
Trypanosoma cruzi GMP reductase 0.0205 1 0.5
Toxoplasma gondii IMP dehydrogenas 0.0205 1 0.5
Leishmania major guanosine monophosphate reductase 0.0205 1 0.5
Mycobacterium leprae Probable inosine-5'-monophosphate dehydrogenase GuaB2 (IMP dehydrogenase) (IMPDH) (IMPD) 0.0205 1 1
Trypanosoma cruzi GMP reductase 0.0205 1 0.5
Plasmodium vivax inosine-5'-monophosphate dehydrogenase, putative 0.02 0.9567 0.5

Activities

Activity type Activity value Assay description Source Reference
EC50 (functional) = 5.05 Agonist activity at rat histamine H4 receptor expressed in HEK293 cells coexpressing Gqi5 protein assessed as calcium flux by FLIPR assay ChEMBL. 18811133
Efficacy (functional) = 68 % Agonist activity at rat histamine H4 receptor expressed in HEK293 cells coexpressing Gqi5 protein assessed as calcium flux by FLIPR assay relative to histamine ChEMBL. 18811133
pKb (functional) = 5.99 Antagonist activity at human histamine H4 receptor expressed in HEK293 cells coexpressing Gqi5 protein assessed as calcium flux by FLIPR assay ChEMBL. 18811133

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.